IGF2BP3 Overexpression Accelerates Osteoarthritis Progression by Promoting Glycolysis via m6A‐Dependent Stabilization of ECM1 mRNA
Investigation of the role of the m6A reader insulin‐like growth factor 2 mRNA‐binding protein 3 (IGF2BP3) in OA progression revealed elevated levels of IGF2BP3, ECM1, m6A modification, and glycolytic activity in OA cartilage and IL‐1β‐treated chondrocytes, mitigating cartilage damage and matrix breakdown in vivo.